Home › Funds › Balyasny Asset Management › CTNM
Balyasny Asset Management position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.52M sh
Reported value held$24.96M
Portfolio Weight0.03%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 951.32K | $11.18M | New |
| Q4 2025 | 1.84M | $21.06M | Add |
| Q1 2026 | 1.69M | $22.01M | Reduce |
| Q2 2026 | 1.52M | $24.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTNM
- Janus Henderson Group 2.73M sh · $35.59M · Q1 2026
- BlackRock Inc 2.06M sh · $33.83M · Q2 2026
- Franklin Resources 1.84M sh · $30.14M · Q2 2026
- Fidelity Management & Research (FMR) 1.04M sh · $17.05M · Q2 2026
- Millennium Management 931.71K sh · $15.27M · Q2 2026
- Vanguard Group 1.27M sh · $14.53M · Q4 2025
- Geode Capital Management 693.19K sh · $11.36M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $10.97M · Q2 2026
- Goldman Sachs Group 497.25K sh · $8.15M · Q2 2026
- Citadel Advisors 396.35K sh · $6.50M · Q2 2026
- Northern Trust Corp 277.80K sh · $4.55M · Q2 2026